Evaluation of inflammatory markers as prognostic factors in the treatment of hepatocellular carcinoma (HCC) with degradable starch microspheres by transarterial chemoembolization (DSM-TACE)

Objective: To evaluate the prognostic value of pre-therapeutic inflammatory markers before transarterial chemoembolization with degradable starch microspheres (DSM-TACE) in the treatment of hepatocellular carcinoma (HCC). Methods: A total of 155 patients (81% male, median age: 68 years) who underwen...

Full description

Saved in:
Bibliographic Details
Main Authors: Steinberg, Hannah Luisa (Author) , Tropotel, Andriana (Author) , Theysohn, Jens M. (Author) , Schaarschmidt, Benedikt (Author) , Haubold, Johannes (Author) , Jeschke, Matthias (Author) , Jochheim, Leonie (Author) , Ludwig, Johannes Maximilian (Author)
Format: Article (Journal)
Language:English
Published: 14 February 2025
In: Cancers
Year: 2025, Volume: 17, Issue: 4, Pages: 1-14
ISSN:2072-6694
DOI:10.3390/cancers17040647
Online Access:Verlag, kostenfrei, Volltext: https://doi.org/10.3390/cancers17040647
Verlag, kostenfrei, Volltext: https://www.mdpi.com/2072-6694/17/4/647
Get full text
Author Notes:Hannah L. Steinberg-Vorhoff, Andriana Tropotel, Jens M. Theysohn, Benedikt Schaarschmidt, Johannes Haubold, Matthias Jeschke, Leonie Jochheim and Johannes M. Ludwig

MARC

LEADER 00000naa a2200000 c 4500
001 1931446873
003 DE-627
005 20250722101750.0
007 cr uuu---uuuuu
008 250722s2025 xx |||||o 00| ||eng c
024 7 |a 10.3390/cancers17040647  |2 doi 
035 |a (DE-627)1931446873 
035 |a (DE-599)KXP1931446873 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Steinberg, Hannah Luisa  |d 1992-  |e VerfasserIn  |0 (DE-588)1278617353  |0 (DE-627)1831526859  |4 aut 
245 1 0 |a Evaluation of inflammatory markers as prognostic factors in the treatment of hepatocellular carcinoma (HCC) with degradable starch microspheres by transarterial chemoembolization (DSM-TACE)  |c Hannah L. Steinberg-Vorhoff, Andriana Tropotel, Jens M. Theysohn, Benedikt Schaarschmidt, Johannes Haubold, Matthias Jeschke, Leonie Jochheim and Johannes M. Ludwig 
264 1 |c 14 February 2025 
300 |b Diagramme 
300 |a 14 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 22.07.2025 
520 |a Objective: To evaluate the prognostic value of pre-therapeutic inflammatory markers before transarterial chemoembolization with degradable starch microspheres (DSM-TACE) in the treatment of hepatocellular carcinoma (HCC). Methods: A total of 155 patients (81% male, median age: 68 years) who underwent first-time DSM-TACE between 07/13 and 06/22 were included in the study. Inflammatory indices were dichotomized using median values. Cox proportional hazard model for univariate (UVA) and multivariate (MVA) analyses (hazard ratio; 95% CI, p-value) and Kaplan-Meier analyses (overall survival (OS) in months; 95% CI; log-rank test) were performed. Results: The median OS of the study cohort was 15.9 (12.9-20) months with a median survival according to BCLC stages A (12%), B (41%), and C (47%) of median not reached, 19.3 (15.3-27), and 7.2 (4.5-9.0) months, respectively (p < 0.0001). In the UVA, several inflammatory markers on OS were statistically significant with the systemic inflammatory response index (SIRI; ≤median (2.04) HR: 0.41 (0.19-0.89); p = 0.024) and the lymphocyte to monocyte ratio (LMR; >median (1.82) HR: 0.44 (0.2-0.9); p = 0.025) remaining statistically significant in MVA together with the BCLC stage (p = 0.0001), ALBI grade (p = 0.016), hepatic tumor burden (≤25% vs. >25%; p = 0.006), and largest HCC lesion (≤5.5 cm vs. >5.5 cm; p = 0.008). In subgroup analysis, patients with elevated LMR and reduced SIRI exhibited significantly prolonged overall survival (OS) in both BCLC B (p < 0.0001) and Child-Pugh A (p = 0.021) subgroups. Conclusion: The findings suggest that SIRI and LMR may serve as valuable tools in identifying BCLC B and Child-Pugh A patients who could potentially benefit better from DSM-TACE treatment. Nevertheless, further research is recommended to confirm these findings and to provide more comprehensive insights. 
650 4 |a bridging to transplantation 
650 4 |a carcinoma 
650 4 |a chemoembolization 
650 4 |a degradable starch microsphere (DSM) TACE 
650 4 |a hepatocellular 
650 4 |a inflammatory markers 
650 4 |a therapeutic 
700 1 |a Tropotel, Andriana  |e VerfasserIn  |4 aut 
700 1 |a Theysohn, Jens M.  |e VerfasserIn  |4 aut 
700 1 |a Schaarschmidt, Benedikt  |e VerfasserIn  |4 aut 
700 1 |a Haubold, Johannes  |e VerfasserIn  |4 aut 
700 1 |a Jeschke, Matthias  |e VerfasserIn  |4 aut 
700 1 |a Jochheim, Leonie  |e VerfasserIn  |4 aut 
700 1 |a Ludwig, Johannes Maximilian  |d 1984-  |e VerfasserIn  |0 (DE-588)1072015560  |0 (DE-627)826782949  |0 (DE-576)433484144  |4 aut 
773 0 8 |i Enthalten in  |t Cancers  |d Basel : MDPI, 2009  |g 17(2025), 4, Artikel-ID 647, Seite 1-14  |h Online-Ressource  |w (DE-627)614095670  |w (DE-600)2527080-1  |w (DE-576)313958548  |x 2072-6694  |7 nnas  |a Evaluation of inflammatory markers as prognostic factors in the treatment of hepatocellular carcinoma (HCC) with degradable starch microspheres by transarterial chemoembolization (DSM-TACE) 
773 1 8 |g volume:17  |g year:2025  |g number:4  |g elocationid:647  |g pages:1-14  |g extent:14  |a Evaluation of inflammatory markers as prognostic factors in the treatment of hepatocellular carcinoma (HCC) with degradable starch microspheres by transarterial chemoembolization (DSM-TACE) 
856 4 0 |u https://doi.org/10.3390/cancers17040647  |x Verlag  |x Resolving-System  |z kostenfrei  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2072-6694/17/4/647  |x Verlag  |z kostenfrei  |3 Volltext 
951 |a AR 
992 |a 20250722 
993 |a Article 
994 |a 2025 
998 |g 1072015560  |a Ludwig, Johannes Maximilian  |m 1072015560:Ludwig, Johannes Maximilian  |d 60000  |d 62900  |e 60000PL1072015560  |e 62900PL1072015560  |k 0/60000/  |k 1/60000/62900/  |p 8  |y j 
999 |a KXP-PPN1931446873  |e 4748707372 
BIB |a Y 
SER |a journal 
JSO |a {"relHost":[{"physDesc":[{"extent":"Online-Ressource"}],"origin":[{"publisherPlace":"Basel","dateIssuedDisp":"2009-","dateIssuedKey":"2009","publisher":"MDPI"}],"id":{"eki":["614095670"],"zdb":["2527080-1"],"issn":["2072-6694"]},"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"pubHistory":["1.2009 -"],"part":{"year":"2025","pages":"1-14","issue":"4","volume":"17","text":"17(2025), 4, Artikel-ID 647, Seite 1-14","extent":"14"},"disp":"Evaluation of inflammatory markers as prognostic factors in the treatment of hepatocellular carcinoma (HCC) with degradable starch microspheres by transarterial chemoembolization (DSM-TACE)Cancers","type":{"bibl":"periodical","media":"Online-Ressource"},"note":["Gesehen am 27.05.2020"],"recId":"614095670","language":["eng"],"title":[{"title":"Cancers","title_sort":"Cancers"}]}],"physDesc":[{"extent":"14 S.","noteIll":"Diagramme"}],"id":{"doi":["10.3390/cancers17040647"],"eki":["1931446873"]},"origin":[{"dateIssuedDisp":"14 February 2025","dateIssuedKey":"2025"}],"name":{"displayForm":["Hannah L. Steinberg-Vorhoff, Andriana Tropotel, Jens M. Theysohn, Benedikt Schaarschmidt, Johannes Haubold, Matthias Jeschke, Leonie Jochheim and Johannes M. Ludwig"]},"language":["eng"],"recId":"1931446873","type":{"bibl":"article-journal","media":"Online-Ressource"},"note":["Gesehen am 22.07.2025"],"title":[{"title_sort":"Evaluation of inflammatory markers as prognostic factors in the treatment of hepatocellular carcinoma (HCC) with degradable starch microspheres by transarterial chemoembolization (DSM-TACE)","title":"Evaluation of inflammatory markers as prognostic factors in the treatment of hepatocellular carcinoma (HCC) with degradable starch microspheres by transarterial chemoembolization (DSM-TACE)"}],"person":[{"role":"aut","roleDisplay":"VerfasserIn","display":"Steinberg, Hannah Luisa","given":"Hannah Luisa","family":"Steinberg"},{"given":"Andriana","family":"Tropotel","role":"aut","display":"Tropotel, Andriana","roleDisplay":"VerfasserIn"},{"role":"aut","roleDisplay":"VerfasserIn","display":"Theysohn, Jens M.","given":"Jens M.","family":"Theysohn"},{"role":"aut","display":"Schaarschmidt, Benedikt","roleDisplay":"VerfasserIn","given":"Benedikt","family":"Schaarschmidt"},{"roleDisplay":"VerfasserIn","display":"Haubold, Johannes","role":"aut","family":"Haubold","given":"Johannes"},{"given":"Matthias","family":"Jeschke","role":"aut","roleDisplay":"VerfasserIn","display":"Jeschke, Matthias"},{"display":"Jochheim, Leonie","roleDisplay":"VerfasserIn","role":"aut","family":"Jochheim","given":"Leonie"},{"family":"Ludwig","given":"Johannes Maximilian","display":"Ludwig, Johannes Maximilian","roleDisplay":"VerfasserIn","role":"aut"}]} 
SRT |a STEINBERGHEVALUATION1420